Literature DB >> 9341188

The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain.

J C Deloulme1, L Prichard, O Delattre, D R Storm.   

Abstract

A growing family of proteins is regulated by protein kinase C and calmodulin through IQ domains, a regulatory motif originally identified in neuromodulin (Alexander, K. A., Wakim, B. T., Doyle, G. S., Walsh, K. A., and Storm, D. R. (1988) J. Biol. Chem. 263, 7544-7549). Here we report that EWS, a nuclear RNA-binding prooncoprotein, contains an IQ domain, is phosphorylated by protein kinase C, and interacts with calmodulin. Interestingly, PKC phosphorylation of EWS inhibits its binding to RNA homopolymers, and conversely, RNA binding to EWS interferes with PKC phosphorylation. Several other RNA-binding proteins, including TLS/FUS and PSF, co-purify with EWS. PKC phosphorylation of these proteins also inhibits their binding to RNA in vitro. These data suggest that PKC may regulate interactions of EWS and other RNA-binding proteins with their RNA targets and that IQ domains may provide a regulatory link between Ca2+ signal transduction pathways and RNA processing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9341188     DOI: 10.1074/jbc.272.43.27369

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion.

Authors:  A T Akhmedov; B S Lopez
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

Review 2.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

3.  Phosphorylation by SR kinases regulates the binding of PTB-associated splicing factor (PSF) to the pre-mRNA polypyrimidine tract.

Authors:  Ching-Jung Huang; Zhaohua Tang; Ren-Jang Lin; Philip W Tucker
Journal:  FEBS Lett       Date:  2006-12-14       Impact factor: 4.124

4.  NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.

Authors:  Annamaria Galietta; Rosalind H Gunby; Sara Redaelli; Paola Stano; Cristiana Carniti; Angela Bachi; Philip W Tucker; Carmen J Tartari; Ching-Jung Huang; Emanuela Colombo; Karen Pulford; Miriam Puttini; Rocco G Piazza; Holger Ruchatz; Antonello Villa; Arianna Donella-Deana; Oriano Marin; Danilo Perrotti; Carlo Gambacorti-Passerini
Journal:  Blood       Date:  2007-05-30       Impact factor: 22.113

Review 5.  The TET family of proteins: functions and roles in disease.

Authors:  Adelene Y Tan; James L Manley
Journal:  J Mol Cell Biol       Date:  2009-09-24       Impact factor: 6.216

6.  Identification of a self-association domain in the Ewing's sarcoma protein: a novel function for arginine-glycine-glycine rich motifs?

Authors:  Debra J Shaw; Robert Morse; Adrian G Todd; Paul Eggleton; Christian L Lorson; Philip J Young
Journal:  J Biochem       Date:  2010-03-07       Impact factor: 3.387

7.  Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells.

Authors:  Vittorio Caropreso; Emad Darvishi; Thomas J Turbyville; Ranjala Ratnayake; Patrick J Grohar; James B McMahon; Girma M Woldemichael
Journal:  J Biol Chem       Date:  2016-03-09       Impact factor: 5.157

8.  Modification of EWS/WT1 functional properties by phosphorylation.

Authors:  J Kim; J M Lee; P E Branton; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

9.  Downstream EWS/FLI1 - upstream Ewing's sarcoma.

Authors:  Heinrich Kovar
Journal:  Genome Med       Date:  2010-01-28       Impact factor: 11.117

10.  CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing.

Authors:  Didier Auboeuf; Dennis H Dowhan; Xiaotao Li; Kimberly Larkin; Lan Ko; Susan M Berget; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.